Select language:  
1800 620 420
Close menu

Translational Research Program Grant recipients

The Leukaemia Foundation has joined forces with America’s The Leukemia & Lymphoma Society (LLS) and the Snowdome Foundation to fund blood cancer research projects with Australian researchers through the LLS Translational Research Program (TRP). The TRP is an LLS initiative that aims to fund new and innovative research that shows high promise for translating basic biomedical knowledge to clinical application.

2022

A/Prof Jane Oliaro

Making CAR-T cell therapy more effective for aggressive lymphoma and multiple myeloma

Jane Oliaro

Professor Richard Lock

Improving outcomes for children with aggressive T-cell acute lymphoblastic leukemia

Professor Richard Lock

2021

Dr. Lev Kats

Transforming discovery into difference, Dr. Lev Kats has multiple myeloma in his sights.

2020

Professor John Pimanda

Optimising azacitidine (AZA) responsiveness in MDS, CMML and AML

Prof. John Pimanda (UNSW)

Professor Ravinda Majeti and Assoc. Professor Daniel Thomas

Personalized Metabolic Targeting of Epigenetic AML Mutations

Ravindra Majeti and Dan Thomas

Leukaemia and lymphoma society logo

Snowdome logo


Last updated on January 30th, 2023

Developed by the Leukaemia Foundation in consultation with people living with a blood cancer, Leukaemia Foundation support staff, haematology nursing staff and/or Australian clinical haematologists. This content is provided for information purposes only and we urge you to always seek advice from a registered health care professional for diagnosis, treatment and answers to your medical questions, including the suitability of a particular therapy, service, product or treatment in your circumstances. The Leukaemia Foundation shall not bear any liability for any person relying on the materials contained on this website.